ECVT Ecovyst Inc.

Q3 2025 10-Q
Filed: Nov 5, 2025Period ending Sep 30, 2025
Health Care
Chemicals & Allied ProductsSEC EDGAR

Ecovyst Inc. (ECVT) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • New risk: Sale of Advanced Materials & Catalysts business for $556M, expected Q1 2026, subject to regulatory approvals and customary closing conditions
  • Material update: Stock Repurchase Program amended to remove four-year time limit; $202.2M remaining for repurchases as of Sept 30, 2025
+3 more insights

Get deeper insights on Ecovyst Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.